Annotation Detail for PDIA2

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002104 |
Cadmium |
Cadmium results in decreased expression of PDIA2 protein | decreases expression | 16440303
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of PDIA2 protein | decreases expression | 16440303
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PDIA2 mRNA | increases expression | 20106945
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides affects the localization of PDIA2 protein | affects localization | 17475668
|
D008070 |
Lipopolysaccharides |
Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of PDIA2 protein] | affects localization|decreases reaction | 17475668
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PDIA2 protein | decreases expression | 19294697
|
D014415 |
Tunicamycin |
Tunicamycin results in decreased expression of PDIA2 mRNA | decreases expression | 17127020
|
C522219 |
Vaticanol B |
Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of PDIA2 protein] | affects localization|decreases reaction | 17475668
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.33 | 18653653 11850527 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.14 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.35 | 16712894 17306315 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.79 | 15687053 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.44 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
12.38 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.38 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.38 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.12 | 19486331 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.79 | 15328337 17637181 15821434 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.14 | 19224547 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.28 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.50 | 12168785 12639820 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.08 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.65 | 16366002 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.40 | 12676792 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.18 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.16 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
2.99 | 17255318 12878042 17963957 9205823 17237260 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.93 | 17255318 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
15.75 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
15.75 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
15.75 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
15.75 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.97 | 12371664 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
5.09 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.26 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.45 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.35 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.36 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.89 | 16712894 17077188 17306315 15276417 19931552 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.06 | 19082730 16487513 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.61 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.02 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.31 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.50 | 17306315 15276417 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.78 | 15687053 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.95 | 11605937 12224865 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.47 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
3.51 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.51 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.90 | 10835634 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.81 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.01 | 12854658 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.43 | 15821434 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.59 | 16452187 16712894 11723127 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.03 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.82 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |